Proposed rules will vastly expand trove of clinical trial data reported in U.S. database

Pharmaceutical companies will need to publicly share results, even for unapproved drugs —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *